FDA Drug Recalls

Recalls / Class II

Class IID-0853-2022

Product

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 Tablets per blister pack, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, NDC 43598-561-78.

Brand name
Lansoprazole
Generic name
Lansoprazole
Active ingredient
Lansoprazole
Route
Oral
NDCs
43598-561, 43598-560
FDA application
ANDA210465
Affected lot / code info
Lot #: T2000645, Exp 07/2022

Why it was recalled

Failed Dissolution Specifications

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Manufacturer
Dr.Reddys Laboratories Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
107 College Rd E, N/A, Princeton, New Jersey 08540-6623

Distribution

Quantity
252 Blister Packs
Distribution pattern
OH

Timeline

Recall initiated
2022-04-15
FDA classified
2022-05-05
Posted by FDA
2022-05-11
Terminated
2023-11-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0853-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Lansoprazole · FDA Drug Recalls